Your browser doesn't support javascript.
loading
Neuroligin-1 is altered in the hippocampus of Alzheimer's disease patients and mouse models, and modulates the toxicity of amyloid-beta oligomers.
Dufort-Gervais, Julien; Provost, Chloé; Charbonneau, Laurence; Norris, Christopher M; Calon, Frédéric; Mongrain, Valérie; Brouillette, Jonathan.
Afiliação
  • Dufort-Gervais J; Department of Pharmacology and Physiology, Université de Montréal, Montréal, Québec, Canada.
  • Provost C; Center for Advanced Research in Sleep Medicine, Hôpital du Sacré-Coeur de Montréal (Recherche CIUSSS-NIM), Montréal, Québec, Canada.
  • Charbonneau L; Center for Advanced Research in Sleep Medicine, Hôpital du Sacré-Coeur de Montréal (Recherche CIUSSS-NIM), Montréal, Québec, Canada.
  • Norris CM; Department of Neuroscience, Université de Montréal, Montréal, Québec, Canada.
  • Calon F; Department of Molecular and Biomedical Pharmacology, Sanders-Brown Center on Aging, University of Kentucky, Lexington, KY, USA.
  • Mongrain V; Neuroscience Unit, Research Center - CHU de Québec, Québec, QC, Canada.
  • Brouillette J; Faculty of Pharmacy, Université Laval, Québec, QC, Canada.
Sci Rep ; 10(1): 6956, 2020 04 24.
Article em En | MEDLINE | ID: mdl-32332783

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Moléculas de Adesão Celular Neuronais / Doença de Alzheimer / Hipocampo Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Moléculas de Adesão Celular Neuronais / Doença de Alzheimer / Hipocampo Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article